e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Treatment of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relationship between pharmacotherapy and severity of disease in patients with COPD
B. Werner, E. Wanka, R. A. Jörres, D. Nowak, M. Pfeifer (Munich, Donaustauf, Germany)
Source:
Annual Congress 2007 - Treatment of COPD
Session:
Treatment of COPD
Session type:
Thematic Poster Session
Number:
581
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Werner, E. Wanka, R. A. Jörres, D. Nowak, M. Pfeifer (Munich, Donaustauf, Germany). Relationship between pharmacotherapy and severity of disease in patients with COPD. Eur Respir J 2007; 30: Suppl. 51, 581
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Comorbidities in COPD patients are not associated to higher disease severity
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011
Is there any relationship between the duration to diagnosis of COPD and severity of the disease?
Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care
Year: 2012
Relationship of anxiety and depression with sociodemographic characteristics in hospitalized patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018
Relationship between dyspnea and depression in the elderly patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Are COPD exacerbations associated with the severity of the disease?
Source: Eur Respir J 2005; 26: Suppl. 49, 300s
Year: 2005
Impact of co-morbidities on the rehabilitation outcome in COPD patients
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007
Changes in the level of melatonin in patients with varying degrees of severity of chronic obstructive pulmonary disease in conjunction with gastroesophageal reflux disease
Source: International Congress 2014 – Comorbidities
Year: 2014
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Relationship between quality of life, exercise capacity and disease severity in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life
Year: 2011
Relationship between quality of life, exercise capacity and disease severity in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Clinical parameters in airway diseases
Year: 2011
Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
The relationship between depression, medication and stage of the disease in patients with COPD
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006
Assessment of treatment efficiency in patients with chronic obstructive pulmonary disease combined with gastroesophageal reflux disease during treatment with melatonin
Source: International Congress 2014 – Clinical presentations
Year: 2014
Prevalence of comorbidity in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001
Biomarkers in COPD patients: Relationship with severity indices
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
Cough rate may predict disease severity in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 536s
Year: 2004
Clinical effectiveness of antidepressive drug in patients with COPD and concomitant moderate depressive episode
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Prevalence of comorbidities in patients with COPD in south-Spain
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Prevalence of anxiety and depression in 196 patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept